Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

G

GRCE

Grace Therapeutics Inc

2.30

Jul 27 • 3:59 PM ET -0.03 (-1.29%)

2.27

Aftermarket • 7:34 PM ET -0.03 (-1.30%)

Healthcare Biotechnology USA Nano NASD

Peers: ATOS INMB LTRN NTRB OTLK QNTM RNXT VERU XLO TLPH

| Held by: VTI IWC

Scroll to Statements

Index	-
Market Cap	37.43M
Enterprise Value	20.45M
Income	-7.79M
Sales	0.00M
Book/sh	3.99
Cash/sh	1.04
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	5
IPO	May 06, 2011

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.58
P/C	2.20
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.10
Current Ratio	8.10
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.48
EPS next Y	-0.61
EPS next Q	-0.13
EPS this Y	-10.04%
EPS next Y	-18.87%
EPS next 5Y	-
EPS past 3/5Y	56.43% 43.17%
Sales past 3/5Y	- -
EPS Y/Y TTM	43.67%
Sales Y/Y TTM	-
EPS Q/Q	-258.41%
Sales Q/Q	-
Earnings	Jun 18 BMO
EPS/Sales Surpr.	73.91% -

Insider Own	25.96%
Insider Trans	0.00%
Inst Own	25.97%
Inst Trans	-0.51%
ROA	-9.81%
ROE	-11.94%
ROIC	-12.20%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-4.19%
SMA50	-2.14%
SMA200	-28.42%
Trades

Shs Outstand	16.02M
Shs Float	12.05M
Short Float	13.54%
Short Ratio	5.30
Short Interest	1.63M
52W High	5.18 -55.60%
52W Low	1.79 28.49%
Volatility	3.57% 6.04%
ATR (14)	0.13
RSI (14)	41.83
Beta	0.38
Rel Volume	0.36
Avg Volume	307.98K
Volume	116,860

Perf Week	-5.35%
Perf Month	-2.95%
Perf Quarter	0.00%
Perf Half Y	-39.79%
Perf YTD	-33.53%
Perf Year	-25.32%
Perf 3Y	-6.50%
Perf 5Y	-89.52%
Perf 10Y	-96.95%
Recom	1.00
Target Price	6.00
Prev Close	2.33
Price	2.30
Change	-1.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)